Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, United States
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, United States
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, United States
Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, United States
Fanglue Peng
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, United States
Yao Ding
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, United States
Brendan M Barton
Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, United States
Xiangdong Lv
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Michael Y Zhao
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Shengyi Sun
Center for Molecular Medicine and Genetics, Wayne State University, Detroit, United States
Yuning Hong
Department of Chemistry and Physics, La Trobe University, Melbourne, Australia
Ling Qi
Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, United States
Stanley Adoro
Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, United States
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, United States
Signals from the pre-T cell receptor and Notch coordinately instruct β-selection of CD4–CD8–double negative (DN) thymocytes to generate αβ T cells in the thymus. However, how these signals ensure a high-fidelity proteome and safeguard the clonal diversification of the pre-selection TCR repertoire given the considerable translational activity imposed by β-selection is largely unknown. Here, we identify the endoplasmic reticulum (ER)-associated degradation (ERAD) machinery as a critical proteostasis checkpoint during β-selection. Expression of the SEL1L-HRD1 complex, the most conserved branch of ERAD, is directly regulated by the transcriptional activity of the Notch intracellular domain. Deletion of Sel1l impaired DN3 to DN4 thymocyte transition and severely impaired mouse αβ T cell development. Mechanistically, Sel1l deficiency induced unresolved ER stress that triggered thymocyte apoptosis through the PERK pathway. Accordingly, genetically inactivating PERK rescued T cell development from Sel1l-deficient thymocytes. In contrast, IRE1α/XBP1 pathway was induced as a compensatory adaptation to alleviate Sel1l-deficiency-induced ER stress. Dual loss of Sel1l and Xbp1 markedly exacerbated the thymic defect. Our study reveals a critical developmental signal controlled proteostasis mechanism that enforces T cell development to ensure a healthy adaptive immunity.